Cell-mediated cytotoxicity against human tumors: lessons learned and future prospects

Receptors for interleukin 2 on human squamous cell carcinoma cell lines and tumor in situ.

Cancer research·1992

The T-cell receptor V beta gene usage in tumor-infiltrating lymphocytes and blood of patients with hepatocellular carcinoma.

Cancer research·1992

Nongranular proteolytic enzymes of rat IL-2-activated natural killer cells. I. Subcellular localization and functional role.

Journal of immunology (Baltimore, Md. : 1950)·1992

Two new human cholangiocarcinoma cell lines and their cytogenetics and responses to growth factors, hormones, cytokines or immunologic effector cells.

International journal of cancer·1992

Role of cytokines in the adoptive immunotherapy of an experimental model of human head and neck cancer by human IL-2-activated natural killer cells.

Journal of immunology (Baltimore, Md. : 1950)·1992

Tissue distribution of adoptively transferred adherent LAK cells: role of the route of administration.

Natural immunity·1992

Phase II evaluation of recombinant gamma-interferon in patients with advanced pancreatic carcinoma: a Southwest Oncology Group study.

Journal of biological response modifiers·1990

A phase II trial of recombinant tumor necrosis factor in patients with metastatic colorectal adenocarcinoma: a Southwest Oncology Group study.

Journal of biological response modifiers·1990

Priming effect of orally administered muramyl dipeptide on induction of endogenous tumor necrosis factor.

Journal of biological response modifiers·1990

Recombinant alpha-interferon enhances tumor targeting of an antimelanoma monoclonal antibody in vivo.

Journal of biological response modifiers·1990

Immunotherapy with lymphokine-activated natural killer cells and recombinant interleukin-2: a feasibility trial in metastatic renal cell carcinoma.

Journal of biological response modifiers·1990

Phase I trial of continuous infusion recombinant interleukin-2 and intermittent recombinant interferon-alpha 2a: clinical effects.

Journal of biological response modifiers·1990

Detecting drug-induced nephrotoxicity using simultaneous label-free autofluorescence multiharmonic microscopy.

Toxicological sciences : an official journal of the Society of Toxicology·2026

Use, survival, and adverse events of dostarlimab monotherapy in advanced or recurrent endometrial cancer: a nationwide cohort study in France.

The oncologist·2026

AK050834 Deficiency Prevents Vascular Aging via Opposite Regulation of Two Senescence-Sensitive Genes ATF3 and p21.

Aging cell·2026

Loss of LCN2 Function Ameliorates Glucocorticoid-Induced Muscle Atrophy via Remodeling the Extracellular Matrix.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026

Selenium Nanoparticles Selectively Target KRAS G13D to Inhibit Colorectal Cancer.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026

Immunotherapy of malignant melanoma using T cell-activating microbeads.

Journal of immunology (Baltimore, Md. : 1950)·2026

Related Experiment Videos

Cell-mediated cytotoxicity against human tumors: lessons learned and future prospects

Related Concept Videos

Receptors for interleukin 2 on human squamous cell carcinoma cell lines and tumor in situ.

The T-cell receptor V beta gene usage in tumor-infiltrating lymphocytes and blood of patients with hepatocellular carcinoma.

Nongranular proteolytic enzymes of rat IL-2-activated natural killer cells. I. Subcellular localization and functional role.

Two new human cholangiocarcinoma cell lines and their cytogenetics and responses to growth factors, hormones, cytokines or immunologic effector cells.

Role of cytokines in the adoptive immunotherapy of an experimental model of human head and neck cancer by human IL-2-activated natural killer cells.

Tissue distribution of adoptively transferred adherent LAK cells: role of the route of administration.

Phase II evaluation of recombinant gamma-interferon in patients with advanced pancreatic carcinoma: a Southwest Oncology Group study.

A phase II trial of recombinant tumor necrosis factor in patients with metastatic colorectal adenocarcinoma: a Southwest Oncology Group study.

Priming effect of orally administered muramyl dipeptide on induction of endogenous tumor necrosis factor.

Recombinant alpha-interferon enhances tumor targeting of an antimelanoma monoclonal antibody in vivo.

Immunotherapy with lymphokine-activated natural killer cells and recombinant interleukin-2: a feasibility trial in metastatic renal cell carcinoma.

Phase I trial of continuous infusion recombinant interleukin-2 and intermittent recombinant interferon-alpha 2a: clinical effects.

Detecting drug-induced nephrotoxicity using simultaneous label-free autofluorescence multiharmonic microscopy.

Use, survival, and adverse events of dostarlimab monotherapy in advanced or recurrent endometrial cancer: a nationwide cohort study in France.

AK050834 Deficiency Prevents Vascular Aging via Opposite Regulation of Two Senescence-Sensitive Genes ATF3 and p21.

Loss of LCN2 Function Ameliorates Glucocorticoid-Induced Muscle Atrophy via Remodeling the Extracellular Matrix.

Selenium Nanoparticles Selectively Target KRAS G13D to Inhibit Colorectal Cancer.

Immunotherapy of malignant melanoma using T cell-activating microbeads.

Related Experiment Videos

Cell-mediated cytotoxicity against human tumors: lessons learned and future prospects

Related Concept Videos

Related Articles